Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Reexamination Certificate
2006-09-12
2006-09-12
Parkin, J. S. (Department: 1648)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Amino acid sequence disclosed in whole or in part; or...
C424S208100
Reexamination Certificate
active
07105164
ABSTRACT:
A method of generating an HIV-specific cytotoxic T-cell response in a host involves an initial administration of a T-helper molecule to the host to prime T-helper cells of the immune system of the host and a subsequent administration to the host of a mixture of the T-helper molecule and a T-cell inducing HIV-derived molecule to generate an HIV-specific T-cell response in the host.
REFERENCES:
patent: 4882145 (1989-11-01), Thornton et al.
patent: 5639854 (1997-06-01), Sia et al.
patent: 5840303 (1998-11-01), Chisari et al.
patent: 6024965 (2000-02-01), van Baalen et al.
patent: 470 980 (1990-05-01), None
patent: 534 615 (1992-08-01), None
patent: 534 618 (1992-08-01), None
patent: 470 980 (1994-03-01), None
patent: WO 98/22317 (1995-08-01), None
patent: WO 95/34308 (1995-12-01), None
patent: WO 96/12733 (1996-05-01), None
Blazevic V., Ranki A., Krohn J.E.K., AIDS Research & Human Retrovirus vol. 11, (11) 1995, pp. 1335-1342.
Blazevic V. et al., Journal or Acquired Immune Deficiency Syndromes 6:881-890, 1995.
Schonbach Christian et al. Virology 226, 102-112 (1996).
Deprez B. et al., Vaccine 1996, vol. 14, No. 5 pp. 375-382.
Haynes F. B., Putman B. S., Weinberg B. J., The Finnish Medical Society DOUCECIM, Ann Med' 28, 1996, pp. 39-41.
Ian A Wilson and David H Fremont. Seminars in Immunology, vol. 5, pp. 75-80, 1993.
Kirsten Falk and Olaf Rotzschke. Seminars in Immunolgy, vol. 5, pp. 81-94, 1993.
Victor H Engelhard. Current Opinion in Immunology, vol. 6, pp. 13-23, 1994.
Salter R D and Creswell P. EMBO J., vol. 5, pp. 943, 1986.
Townsend A. et al. Nature, vol. 340, pp. 443, 1989.
Yuping Deng et al. Journal of Immunology, vol. 158, pp. 1507-1515, 1997.
Van Baalen et al. Human Immunodeficiency virus type. vol. 78, No. 8, Aug. 1997 1913-1918.
Fahey J.L.& Schooley R. Clin. exp. Immunol (1992) 88, 1-5.
Fox L. Jeffrey, No winners against AIDS, Bio/Technology vol. 12 (1994) p. 128.
Chong Pele
Klein Michel H.
Sia Charles D. Y.
Parkin J. S.
Sanofi Pasteur Limited
Sim & McBurney
Stewart Michael I.
LandOfFree
HIV-specific cytotoxic T-cell responses does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with HIV-specific cytotoxic T-cell responses, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and HIV-specific cytotoxic T-cell responses will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3593756